MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Disparities in Access to DBS Surgery Based on Demographics of Patients with PD Admitted for DBS Surgery in the United States from 2003 to 2013

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand current demographics of DBS use and identify non-medical barriers to its utilization. Background: Parkinson’s Disease (PD) has seen increasingly more sophisticated…
  • 2017 International Congress

    Movement Disorders in Demyelinating Diseases: a retrospective review from a tertiary academic center.

    G. Suarez-Cedeno, M. Raja (Houston, TX, USA)

    Objective: To review the prevalence of movement disorders (MD) in patients with demyelinating diseases (DD) treated at a tertiary academic center and to characterize their therapeutic response…
  • 2017 International Congress

    Body mass index, change in body mass index and risk of Parkinson`s disease

    J. Lee, J.H. Kim, J.H. Cho, G.S. Kim, J.H. Lee, P.H. Lee, Y.H. Sohn (Goyang-shi, Republic of Korea)

    Objective:  Our aim is to show the association between BMI and risk of PD and to evaluate how change in BMI is associated with occurrence…
  • 2017 International Congress

    Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

    C. Cattaneo (Bresso (Milan), Italy)

    Objective: To investigate the efficacy of safinamide, compared to placebo, as add-on therapy to stable doses of levodopa, on both motor and non-motor symptoms in…
  • 2017 International Congress

    Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease

    A.C. Campos, E. Talamoni Fonoff, C. Hamani, R. Lima Pagano (São Paulo, Brazil)

    Objective: To better understand the benefits of DBS in non-motor symptoms. Background: Parkinson's disease(PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons,…
  • 2017 International Congress

    Parkinson Disease-Associated Polyneuropathy: A Biomarker of Disease Severity?

    M. Rosso, A. Merola, A. Romagnolo, C. Comi, A. Fasano, M. Zibetti, R. Lopez-Castellanos, D. Cocito, L. Lopiano, A. Espay (Cincinnati, OH, USA)

    Objective: Objective: We sought to examine the association between Parkinson disease (PD) associated polyneuropathy (PD-PNP) and levodopa dose, age, and disease duration in a cross-sectional,…
  • 2017 International Congress

    An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.

    Y. Yamanishi, R. Ando, C. Yamasaki, S. Tada, N. Miyaue, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, M. Nomoto (Ehime, Japan)

    Objective: To evaluate an association between impulse control disorders (ICDs) and dopamine agonists (DA) therapy in Japanese patients with Parkinson’s disease (PD). Background: ICDs such…
  • 2017 International Congress

    Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, A. Numao, H. Fujita, Y. Watanabe, T. Matsubara, M. Miyamoto, K. Kaga, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

    Objective: To evaluate the association between melatonin secretion rhythm and nocturnal polyuria, and the pathophysiology of nocturnal polyuria in PD. Background: Patients with PD have…
  • 2017 International Congress

    Parkinson’s Disease from the Patient Perspective

    L. Mischley, G. Canada, R. Lau (Kenmore, WA, USA)

    Objective: The purpose of this study was to describe the constellation of parkinsonian symptoms, as experienced by the patient. Background: For 200 years, the cardinal…
  • 2017 International Congress

    A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

    V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

    Objective: To evaluate safety, tolerability and efficacy of botulinum toxin type A for limb pain in advanced Parkinson´s disease (PD). Background: Pain is a frequent…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley